Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
PharmTech
January 4, 2018
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

Top Pharmaceutical Technology News Stories of 2017

Pharma Gives Update on Puerto Rico Manufacturing Operations

AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly and Company said they are working to restore normal operations at their respective facilities and continuing recovery efforts.
/ read more /


EMA to Relocate to New HQ in Amsterdam in Wake of Brexit

Following a vote by member states in favor of Amsterdam as the agency’s new headquarters, the relocation will take place over the next 16 months, with operations expected to start up in March 2019.
/ read more /


FDA to Recognize Inspections from EU Drug Authorities

A mutual recognition agreement to accept inspection data from eight EU regulatory authorities may reduce inspection burdens at global drug facilities.
/ read more /

advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers
subscribe
advertisement

2018 PDA Annual Meeting
The 2018 PDA Annual Meeting will deliver the same high-quality content attendees expect in a NEW meeting format that starts on Monday afternoon. Delve into the future of bio/pharmaceutical manufacturing with the latest updates on the end user/patient perspective, innovative manufacturing strategies, and disruptive technologies. The industry's increased use of big data, artificial intelligence and robotics will also be explored. Learn more and register today.


Catalent to Acquire Cook Pharmica for $950 Million

The acquisition adds to Catalent’s capabilities in biologics development, analytical services, manufacturing, and finished product supply.
/ read more /


FDA Approves Novartis’ CAR-T Drug, First Gene Therapy Approval in US

FDA approves Novartis’ CAR-T therapy, marking the first time a cell therapy based on gene transfer has been approved in the United States for any indication.
/ read more /


Congress Meets Deadline for Reauthorizing FDA User Fees

The Senate voted 94–1 to approve legislation reauthorizing user fees and a series of program changes.
/ read more /


Endo Withdraws Opioid Drug from Market

After FDA found a “significant shift in the route of abuse,” Endo voluntarily removes OPANA ER from the market.
/ read more /

FDA Pushes DSCSA Serialization Enforcement Deadline to 2018

The agency has pushed back by one year the deadline for compliance with DSCSA serialization requirements.
/ read more /


Thermo Fisher Scientific to Acquire Patheon

Thermo Fisher will acquire Patheon for approximately $7.2 billion, including the assumption of approximately $2 billion of net debt.
/ read more /


Trump Nominates Scott Gottlieb to Lead FDA

The White House said President Trump will nominate Scott Gottlieb to the position of FDA commissioner.
/ read more /


Top Pharmaceutical Technology Feature Stories of 2017

Establishing Blend Uniformity Acceptance Criteria for Oral Solid-Dosage Forms

This article introduces the concepts of pooled variance and the central limit theorem, which are intended for establishing acceptance criteria for blend uniformity data of granular powder blends when a significant degree of sampling bias is involved.
/ read more /


Key Considerations in Capsule Filling

Capsule filling is a complex process, and the product to be encapsulated must be well developed to ensure mass uniformity.
/ read more /


Designing Optimized Formulations

Design of experiment plays a crucial role in the optimization process of formulation development.
/ read more /


Comparison of Permitted Daily Exposure with 0.001 Minimal Daily Dose for Cleaning Validation

In this study, the authors investigated the relationship between the 0.001 MinDD and the PDE values for 140 drug substances as an attempt to identify high-risk groups of products for patient safety. This comparison can serve as a method for prioritization of APIs for development of PDEs.
/ read more /


PAT for Continuous API Manufacturing Progresses

Advances in process analytical technology have been achieved, but significant challenges remain.
/ read more /

Evaluating Progress in Analytical Quality by Design

The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of analytical quality by design concepts.
/ read more /


Understanding Dissolution Testing

Industry experts discuss best practices for dissolution testing of poorly soluble, immediate-release, and controlled-release formulations and the different analytical approaches used.
/ read more /


Oral Delivery of Biologic APIs: The Challenge Continues

Effective solutions for overcoming the high molecular weight, hydrophilicity, and instability of large biomolecules have yet to be identified.
/ read more /


Achieving Manufacturing Excellence

Moving to the next level of productive, reliable performance in bio/pharmaceutical manufacturing requires a willingness to make changes and create a quality culture.
/ read more /


Characterization and Impurity Analysis of Oligonucleotide Therapeutics

Analytical technologies play a key role in the characterization and quantitation of oligonucleotide therapeutics.
/ read more /


UPCOMING WEBCAST

Considerations for Launching a Biopharm Company in 2018
Live Webcast: Wednesday, January 31 at 10:00am EST
Register now


ON DEMAND WEBCASTS

Risk Assessment and Testing Requirements for Elemental Impurities in Pharmaceutical Products
On Demand
Learn more


The Journey to a Successful Biologic License Application
On Demand
Learn more


Events

Pharmapack Europe

February 7–8, 2018

IFPAC-2018

February 11–14, 2018

ISPE 2018 Facilities of the Future Conference

February 20–22, 2018

more events

eBOOKS

Vaccines Development and Manufacturing 2017

Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible.


contribute | contact editors | CONTACT SALES | subscribe | advertise